Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Journal of Environmental Pathology, Toxicology and Oncology
Импакт фактор: 1.625 5-летний Импакт фактор: 1.63 SJR: 0.402 SNIP: 0.613 CiteScore™: 2.3

ISSN Печать: 0731-8898
ISSN Онлайн: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvPathToxOncol.v22.i3.10
19 pages

Mechanisms of Metastasis as Related to Receptor Tyrosine Kinases in Small-Cell Lung Cancer

Nazia F. Jafri
Lowe Center for Thoracic Oncology,Dept.of Medical Oncology,Dana-Farber Cancer Institute;Div.of Medical Oncology and Dept.of Medicine,Brigham and Women's Hospital;Harvard Medical School; Boston University Medical School, Boston, Massachusetts, USA
Patrick C. Ma
Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; Brigham and Women’s Hospital; Harvard Medical School; Tufts-New England Medical Center, Boston, Massachusetts;University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
Ravi Salgia
Department of Medical Oncology and Therapeutics Research, Comprehensive Cancer Center, City of Hope National Medical Center

Краткое описание

Small-cell lung cancer (SCLC) is an aggressive, malignant neoplasm with a 5-year survival of less than 10%. This poor survival rate is related to a high propensity for recurrence and a high rate of metastases. Metastases initially occur in the lymph nodes and thereafter in other organs such as the lung itself, liver, adrenal glands, brain, bone, and bone marrow. The mechanisms of metastases have been better understood recently and are described in this review. Receptor tyrosine kinases (RTKs) have been identified as important therapeutic targets in non-small-cell lung cancer (such as the EGF-receptor). We have begun to identify RTKs in SCLC and have shown that c-Kit and c-Met are expressed and functional in SCLC. RTKs have also been shown to be important in the metastasis of cancer cells. The roles of RTKs in the mechanism of metastasis are detailed in this review, with special emphasis on downstream signal transduction from RTK signaling.


Articles with similar content:

MicroRNAs in Bladder Cancer: Expression Profiles, Biological Functions, Regulation, and Clinical Implications
Critical Reviews™ in Eukaryotic Gene Expression, Vol.24, 2014, issue 1
Zhaoqi Shi, Mingxin Zhang, Junjun She, Qingxia Wei
KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 3
S. Niranjali Devaraj, Venugopal Vinod Prabhu
Copine 3 as a Novel Potential Drug Target for Non-Small-Cell Lung Carcinoma
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 2
Kunnathur Murugesan Sakthivel , Venugopal Vinod Prabhu
DLK1-MEG3 Imprinted Domain MicroRNAs in Cancer Biology
Critical Reviews™ in Eukaryotic Gene Expression, Vol.22, 2012, issue 1
George Vartholomatos, Evangelos Voulgaris, Leonidas Benetatos
Stem Cell Marker OCT3/4 in Tumor Biology and Germ Cell Tumor Diagnostics: History and Future
Critical Reviews™ in Oncogenesis, Vol.12, 2006, issue 3-4
Jeroen de Jong, Leendert H. J. Looijenga